ELOXATIN 100MG VIAL 100 mg Concentrate for solution for infusion Vial

Product Overview

ELOXATIN 100mg Vial is a concentrate for solution for infusion, containing the active ingredient Oxaliplatin.

It is an advanced chemotherapy medication used primarily in the treatment of various types of cancer.

This potent drug works by interfering with the growth of cancer cells, thereby slowing their spread in the body.

ELOXATIN is administered under strict medical supervision in a clinical setting.

Benefits of Use

• Helps in the treatment of metastatic colorectal cancer, often in combination with fluorouracil and leucovorin.
• May be used as adjuvant treatment of stage III colon cancer after complete resection of the primary tumor.
• Works to inhibit DNA synthesis and repair in cancer cells, leading to their destruction.
• Contributes to improving progression-free survival and overall survival in eligible patients.

How to Use

1. ELOXATIN is administered intravenously as an infusion, typically over 2 to 6 hours.
2. The dosage is determined by a qualified oncologist based on the patient's body surface area, medical condition, and other concomitant therapies.
3. It is usually given as part of a combination chemotherapy regimen, with treatment cycles typically repeated every two weeks.
4. Administration must be performed by healthcare professionals experienced in the use of anti-neoplastic agents in a hospital or clinic setting.
5. Patients will be closely monitored for adverse reactions during and after the infusion.

Caution & Warnings

• Severe Neuropathy: ELOXATIN can cause peripheral sensory neuropathy, which can be severe and persistent.
• Myelosuppression: Bone marrow suppression (decreased white blood cells, red blood cells, and platelets) is a common and potentially severe side effect.
• Hypersensitivity Reactions: Allergic reactions, including anaphylaxis, can occur during or shortly after infusion.
• Gastrointestinal Toxicity: Nausea, vomiting, diarrhea, and mucositis are common; anti-emetics and supportive care are often required.
• Pulmonary Toxicity: Rare but serious interstitial lung disease or pulmonary fibrosis can occur.
• Hepatotoxicity: Liver function should be monitored throughout treatment.
• Pregnancy and Lactation: ELOXATIN can cause fetal harm and should not be used during pregnancy. Breastfeeding is not recommended during treatment.
• Renal Impairment: Exercise caution and adjust dosage in patients with pre-existing renal dysfunction.
• Hepatic Impairment: Use with caution in patients with severe hepatic impairment.
• Medical Supervision: This medication must only be administered by qualified medical personnel in a setting equipped to manage potential serious side effects.

Ingredients

Each vial contains:

Oxaliplatin: 100 mg

Excipients: Water for injection.

Product Details

Brand: ELOXATIN

Manufacturer: Sanofi

Form: Concentrate for solution for infusion

Strength: 100 mg

Package Type: Vial

Storage Conditions: Store below 25°C. Do not freeze. Protect from light.